| ClinicalTrials.gov Identifier: |
NCT00050778 |
| Brief Title: |
A Phase II Study Comparing Low- and High-Dose Alemtuzumab and High-Dose Rebif® in Patients With Early, Active Relapsing-Remitting Multiple Sclerosis |
|
|
First Submitted : |
December 19, 2002 |
|
First Submitted that Met QC Criteria : |
December 20, 2002 |
|
First Posted : |
December 23, 2002
(Estimate)
|
|
|
Results First Submitted : |
November 3, 2008 |
|
Results First Submitted that Met QC Criteria : |
July 13, 2009 |
|
Results First Posted : |
August 25, 2009
(Estimate)
|
|
|
Last Update Submitted that Met QC Criteria : |
January 6, 2015 |
|
Last Update Posted : |
January 8, 2015
(Estimate)
|
|
